Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor–Sparing Antiretroviral Therapy in a High–HBV Endemicity Setting

BACKGROUND: We monitored the evolution of markers of hepatitis B virus (HBV) infection in virologically suppressed HIV-positive patients switching to nucleoside reverse transcriptase inhibitor (NRTI)–sparing antiretroviral therapy within a randomized trial in Cameroon. METHODS:  HBV surface antigen...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdullahi, Adam, Fopoussi, Olga Mafotsing, Torimiro, Judith, Atkins, Mark, Kouanfack, Charles, Geretti, Anna Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201150/
https://www.ncbi.nlm.nih.gov/pubmed/30377627
http://dx.doi.org/10.1093/ofid/ofy251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201150/
https://www.ncbi.nlm.nih.gov/pubmed/30377627
http://dx.doi.org/10.1093/ofid/ofy251

Ejemplares similares